Media Library
icon
-
ImagelockManufacturing / Image
Novartis Site in Stein, Switzerland
Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockManufacturing / Image
Operator with Culture Medium Bag
A process operator with culture medium bag. Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockLocations / Image
Bad Säckingen Novartis Stein, Switzerland
Manufacturing facility for innovative cell and gene therapies in Stein, Switzerland. -
ImagelockLeadership / Image
Simon Moroney, D.Phil.
Board member since 2020 | Vice-Chair since 2022 -
ImagelockLeadership / Image
Bridgette Heller
Board member since 2020 -
ImagelockLeadership / Image
Lutz Hegemann, M.D., Ph.D.
President, Global Health and Swiss Country Affairs -
ImagelockMalaria Initiative / Image
Young Malaria Patient
A young malaria patient being given a dose of pediatric antimalarial medicine at the AMREF Clinic in the Kibera area of Nairobi, Kenya. -
ImagelockManufacturing / Image
Worldwide Distribution Center for the Novartis Antimalarial in Basel, Switzerland
Worldwide distribution center for the Novartis antimalarial in Basel, Switzerland: an employee checks a shipment headed for Mozambique for the US Presidential Malaria Initiative. -
ImagelockLocations / Image
View of the Fabrikstrasse, Novartis HQ
-
ImagelockScience & Innovation / Image
T-Cell arrival at the Novartis manufacturing facility
A cancer patient's frozen T-Cells arrive at a Novartis facility to be reengineered. -
ImagelockNovartis Social Business / Image
SMS for Life Training Session
SMS for Life training session teaching healthcare workers how to use text messaging to monitor stock levels of life-saving antimalarials. In Kenya, Machacos district, SMS for Life also includes patient surveillance data on the testing of malaria patients and the use of artemisinin-based combination therapies (ACTs). -
ImagelockNovartis Social Business / Image
SMS for Life
SMS for Life is an innovative public-private partnership led by Novartis under the umbrella of the Roll Back Malaria Partnership. The program has been rolled out across Tanzania and pilots are taking place in Ghana and Kenya.
Pagination
- ‹ Previous page
- 1
- …
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- › Next page